J7628 Bitolterol mesylate comp con

Bitolterol mesylate, inhalation solution, compounded product, administered through dme, concentrated form, per milligram

• Medicare coverage: Special coverage instructions apply
• Status: active (July 2026 file)
• MUE: max 0 units per day (practitioner), rationale: Compounded Drug Policy